Editor,—Following a recent study demonstrating the lack of efficacy of dexamethasone in bronchiolitis,1Everard has commented that there is little evidence that any specific treatment for bronchiolitis is of major clinical benefit.2The American Academy of Pediatrics (AAP) has issued guidelines for the use of ribavirin in respiratory syncytial virus (RSV) bronchiolitis.3 These guidelines have not been widely accepted in the UK and the indications for ribavirin use remain controversial.

To investigate this further we have recently conducted a nationwide survey of UK paediatricians’ attitudes and use of ribavirin, related to their experience of bronchiolitis. A structured questionnaire was sent …